About Blue Ash Therapeutics
Blue Ash Therapeutics is a company based in Cincinnati (United States) founded in 2008 by Greg Flexter. It operates as a B2B. Blue Ash Therapeutics has raised $250 thousand across 2 funding rounds from investors including CincyTech, Queen City Angels and Ohio Third Frontier. Blue Ash Therapeutics operates in a competitive market with competitors including Acesion Pharma, Thryv Therapeutics, MITEM Pharma, Inomagen and Rhythm Therapeutics, among others.
- Headquarter Cincinnati, United States
- Founders Greg Flexter
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$250 K (USD)
in 2 rounds
-
Latest Funding Round
$250 K (USD), Seed
Apr 23, 2010
-
Investors
CincyTech
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Blue Ash Therapeutics
Blue Ash Therapeutics has successfully raised a total of $250K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $250,000
-
First Round
First Round
(01 Jun 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2010 | Amount | Seed - Blue Ash Therapeutics | Valuation | CincyTech , Queen City Angels |
|
| Jun, 2009 | Amount | Grant - Blue Ash Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Blue Ash Therapeutics
Blue Ash Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include CincyTech, Queen City Angels and Ohio Third Frontier. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CincyTech is engaged in venture capital investments for innovative startups.
|
Founded Year | Domain | Location | |
|
Angel investing is facilitated for startups in Cincinnati.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Blue Ash Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Blue Ash Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Blue Ash Therapeutics Comparisons
Competitors of Blue Ash Therapeutics
Blue Ash Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acesion Pharma, Thryv Therapeutics, MITEM Pharma, Inomagen and Rhythm Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for atrial fibrillation are developed targeting SK ion channels.
|
|
| domain | founded_year | HQ Location |
Provider of therapy services for rare diseases
|
|
| domain | founded_year | HQ Location |
Targeted therapies for multiple diseases are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy for cardiovascular diseases is developed using electroporation.
|
|
| domain | founded_year | HQ Location |
Gene therapy for atrial fibrillation is developed in preclinical stage.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Blue Ash Therapeutics
When was Blue Ash Therapeutics founded?
Blue Ash Therapeutics was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Blue Ash Therapeutics located?
Blue Ash Therapeutics is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
Who is the current CEO of Blue Ash Therapeutics?
Greg Flexter is the current CEO of Blue Ash Therapeutics. They have also founded this company.
Is Blue Ash Therapeutics a funded company?
Blue Ash Therapeutics is a funded company, having raised a total of $250K across 2 funding rounds to date. The company's 1st funding round was a Grant of $440K, raised on Jun 01, 2009.
What does Blue Ash Therapeutics do?
Blue Ash Therapeutics, founded in 2008 in Cincinnati, United States, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and cardiovascular. Develops innovative drugs targeted at treating cardiovascular disorders. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Who are the top competitors of Blue Ash Therapeutics?
Blue Ash Therapeutics's top competitors include Acesion Pharma, Thryv Therapeutics and MITEM Pharma.
Who are Blue Ash Therapeutics's investors?
Blue Ash Therapeutics has 3 investors. Key investors include CincyTech, Queen City Angels, and Ohio Third Frontier.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.